Cargando…
Two-stage revision and systemic antifungal therapy of Candida glabrata primary prosthetic hip infection successfully treated: a case report
BACKGROUND: Overall, fungi are estimated to cause approximately 1% of prosthetic joint infections, Candida glabrata account for less than 10% of these cases. No well-defined treatment strategy is available. CASE PRESENTATION: A 71-year-old Caucasian man with non-insulin-dependent diabetes was admitt...
Autores principales: | Pasticci, Maria Bruna, Papalini, Chiara, Leli, Andrea, Bruno, Gastone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528250/ https://www.ncbi.nlm.nih.gov/pubmed/31109363 http://dx.doi.org/10.1186/s13256-019-2095-7 |
Ejemplares similares
-
Effect of Antifungal-Treated Host Macrophages on Candida glabrata
por: Li, Hong-Bin, et al.
Publicado: (2021) -
Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate
por: Mota, Sandra, et al.
Publicado: (2015) -
Biguanides enhance antifungal activity against Candida glabrata
por: Xu, Shuying, et al.
Publicado: (2018) -
Catechin potentiates the antifungal effect of miconazole in Candida glabrata
por: Hervay, Nora Tóth, et al.
Publicado: (2023) -
Prosthetic joint infection diagnosis applying the three-level European Bone and Joint Infection Society (EBJIS) approach
por: Papalini, Chiara, et al.
Publicado: (2022)